PROFITELLIGENCE/Guest access
!
Financial disclaimer

Profitelligence provides financial data and analytics for informational purposes only. Nothing on this platform constitutes investment advice, a recommendation, or an offer to buy or sell any securities. Past performance does not guarantee future results. Always do your own research and consult a licensed financial advisor before making investment decisions.

Legal agreement

By continuing, you acknowledge that you have read and agree to our Terms of Service and Privacy Policy.

i
Guest mode

You're browsing as a guest. Some features like watchlists and alerts require a free account.

--:--:--
Guest mode— viewing WAT. Sign up free to access all symbols.Sign up
WAT logo

WAT

Waters Corporation

HealthcareDiagnostics & Research

Price performance

Sep 18, 2026
$421.63
$8.09-1.88%
1M
+1.39%
3M
+18.62%
YTD
+10.39%
vs SPY
+4.31%
30d range
393–432
Volatility
23.28%
Signals
Price chart

Company activity

22 events
Company activity
TimeTickerTypeEventQtyPriceValue
08/21WAT8-KWaters Corporation Announces Key Executive Changes
08/04WAT8-KWaters Corporation Reports Strong Q2 2026 Results and Raises Full-Year Guidance
05/22WAT8-KWaters Corporation Re-elects Board Members and Approves Key Proposals at Annual Meeting
05/05WAT8-KWaters Corporation Reports Strong Q1 2026 Results and Raises Full-Year Guidance
03/23WAT8-KWaters Corporation Subsidiary Completes $3.5 Billion Senior Notes Offering
03/16WAT8-KWaters Corporation Completes Acquisition of Becton, Dickinson and Company's Biosciences and Diagnostic Solutions Business
02/09WAT8-KWaters Corporation Completes Spin-off and Combination with BD’s Biosciences and Diagnostic Solutions Businesses
02/09WAT8-KWaters Corporation Reports Strong 2025 Financial Results and Provides 2026 Outlook
01/27WAT8-KWaters Shareholders Approve Share Issuance for BD Biosciences Combination
01/16WAT8-KWaters Corporation Announces Spin-Off of Biosciences and Diagnostic Solutions Business
01/12WAT8-KWaters Corporation Presents Financial Outlook and Proposed Transaction at J.P. Morgan Healthcare Conference
11/04/25WAT8-KWaters Corporation Announces Third Quarter 2025 Financial Results and Raises Guidance
08/04/25WAT8-KWaters Corporation Reports Second Quarter 2025 Financial Results
07/14/25WAT8-KWaters Corporation Announces Proposed Transaction with BD's Biosciences and Diagnostics Solutions
07/14/25WAT8-KWaters Corporation Announces Reverse Morris Trust Transaction with Becton, Dickinson and Company
05/29/25WAT8-KWaters Corporation Amends Credit Agreement
05/23/25WAT8-KWaters Corporation Announces Election Results and Approvals from Annual Stockholder Meeting
05/06/25WAT8-KWaters Corporation Reports Strong First Quarter 2025 Financial Results
02/12/25WAT8-KWaters Corporation Reports Strong 2024 Financial Results and Provides 2025 Guidance
01/13/25WAT8-KWaters Corporation to Present at J.P. Morgan Healthcare Conference
11/01/24WAT8-KWaters Corporation Reports Strong Q3 2024 Results and Raises Guidance
11/01/24WAT8-KWaters Corporation Appoints Heather Knight to Board and Committee

WAT filing record

Waters Corporation (WAT): 22 8-K filings summarized, the most recent on Aug 21, 2026.

What the 8-K filings said

  1. Aug 21, 2026 · high impact

    On August 17, 2026, Waters Corporation announced the resignation of Robert L. Carpio III from his position as Senior Vice President, Waters Analytical Sciences Division, effective August 20, 2026. Tina Wu, currently Senior Vice President, Waters Materials Sciences Division and President, China, will assume the role of…

    Waters Corporation Announces Key Executive Changes
  2. Aug 4, 2026 · high impact

    Waters Corporation announced its financial results for the second quarter of 2026, reporting total revenue of $1.645 billion, which surpassed the high end of the guidance range. Organic revenue grew 7% as reported and 9% in constant currency, driven by broad-based outperformance across both organic revenue and the…

    Waters Corporation Reports Strong Q2 2026 Results and Raises Full-Year Guidance
  3. May 22, 2026 · medium impact

    At the annual meeting of stockholders held on May 21, 2026, Waters Corporation re-elected all nominated directors to its Board, ratified the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm, and approved a non-binding advisory resolution on executive compensation. The…

    Waters Corporation Re-elects Board Members and Approves Key Proposals at Annual Meeting
  4. May 5, 2026 · high impact

    Waters Corporation announced its first quarter 2026 financial results, reporting total revenue of $1.267 billion, which exceeded the high end of the guidance range by $56 million. Organic revenue grew 13% as reported and 11% in constant currency, driven by strong performance in the Analytical Sciences Division. The…

    Waters Corporation Reports Strong Q1 2026 Results and Raises Full-Year Guidance
  5. Mar 23, 2026 · medium impact

    On March 23, 2026, Augusta SpinCo Corporation, a subsidiary of Waters Corporation, completed the public offering of $3.5 billion aggregate principal amount of senior notes due between 2027 and 2036. The notes were issued under an Indenture and are guaranteed by Waters Corporation and certain subsidiaries. The proceeds…

    Waters Corporation Subsidiary Completes $3.5 Billion Senior Notes Offering

SEC filings in the last five years

  • 46 Form 8-K
  • 13 Form 10-Q
  • 5 Form 10-K
  • 2 Form 8-K/A